![]() |
|
|
1 From the Christ Hospital Institute for Medical Research and the Department of Biological Chemistry, College of Medicine, University of Cincinnati, Cincinnati, Ohio
(1) One strain of type I and two strains of type III pneumococcus were made highly resistant to sulfapyridine by serial passage through mice treated with less than curative doses of this drug. The organisms that were made resistant in vivo were also resistant to sulfapyridine in vitro.
(2) A sulfapyridine-sensitive strain of type II pneumococcus was made highly resistant to this drug by serial passage through broth containing increasing concentrations of sulfapyridine. This resistant organism was also insensitive in vivo.
(3) Sulfapyridine resistance was retained by the above strains for more than 200 passages through untreated mice.
(4) The manner in which resistant strains are developed and possible explanations for sulfonamide resistance were mentioned and discussed.
Submitted on November 8, 1941
This article has been cited by other articles:
![]() |
M. LANDY, N. W. LARKUM, E. J. OSWALD, and F. STREIGHTOFF INCREASED SYNTHESIS OF p-AMINOBENZOIC ACID ASSOCIATED WITH THE DEVELOPMENT OF SULFONAMIDE RESISTANCE IN STAPHYLOCOCCUS AUREUS Science, March 19, 1943; 97(2516): 265 - 267. [Abstract] [PDF] |
||||